Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many ...

The FDA also gave full approval to the Novavax COVID vaccine (Nuvaxovid) using this approach, approving it for those ages 65 ...

No, this is not true. Vaccines undergo rigorous safety testing and are continuously monitored for adverse events.

Federal officials unveiled a rigorous regulatory approach to future COVID vaccines that could make it harder for many people ...

The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...

Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.

Since the COVID-19 pandemic, there has been a decline in U.S. vaccine uptake, while widespread misinformation and distrust ...

There also was no link between miscarriage risk and the number of vaccinations a woman had gotten, or whether she’d gotten ...

The FDA also requested Novavax conduct a phase 4 study in patients aged 50 to 64 years without high-risk conditions for severe COVID-19.

While the clearance is only for use in certain groups, Novavax’s long-awaited OK is still seen by analysts as a “win” for the ...

One study found that nearly a third of participants who received a harmless placebo during Covid ... vaccine is already outdated,” said Dr. Daniel Salmon, director of the Institute for Vaccine ...

During an interview in late April with Dr. Phil, Robert F. Kennedy Jr. reiterated his appeal to parents on vaccine safety: ...